Bailong Chuangyuan(SH:605016) Tianfeng Securities·2025-07-15 04:44Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected relative return of over 20% within the next six months [5][17]. Core Insights - The company's revenue and net profit for the first half of 2025 reached 650 million and 171 million yuan, respectively, showing year-on-year growth of 22.29% and 42.68% [1]. - The company's profitability continues to improve, with a net profit margin of approximately 26.5% in Q2 2025, reflecting a year-on-year increase of 2.9 percentage points [1]. - The core product, allulose, is expected to see accelerated growth in the domestic market following its approval as a food ingredient in July 2025 [2]. - The company anticipates significant revenue growth, projecting a 26% to 33% increase in revenue from 2025 to 2027, with net profit expected to grow by 29% to 43% during the same period [2]. Financial Performance Summary - For 2025, the company forecasts revenues of 1.45 billion yuan, with a year-on-year growth rate of 26.31% [4]. - The projected net profit for 2025 is 352 million yuan, representing a 43.33% increase compared to the previous year [4]. - The company's earnings per share (EPS) is expected to be 0.84 yuan in 2025, with a price-to-earnings (P/E) ratio of 26.68 [4]. Market Outlook - The company is well-positioned in the soluble dietary fiber market, with the allulose product expected to benefit from a broad application market and cost optimization trends [2]. - The report highlights that the company’s core export product, allulose, is on the tariff exemption list, minimizing the impact of tariff disturbances on its performance [2].